Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BMS-986406 |
| Trade Name | |
| Synonyms | BMS986406|BMS 986406 |
| Drug Descriptions |
BMS-986406 is a monoclonal antibody that targets LILRB2 (ILT4), resulting in decreased downstream signaling and potentially leading to reduced immunosuppressive effects in the tumor microenvironment, and enhanced antitumor immune response (NCI Drug Dictionary). |
| DrugClasses | LILRB2 Antibody 12 |
| CAS Registry Number | NA |
| NCIT ID | C191955 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BMS-986406 | BMS-986406 | 0 | 1 |
| BMS-986406 + Nivolumab | BMS-986406 Nivolumab | 0 | 1 |